Chapman Financial Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$301K Sell
2,343
-200
-8% -$23.4K 0.2% 104
2026
Q1
$306K Sell
2,543
-200
-7% -$23.1K 0.22% 101
2025
Q4
$289K Hold
2,743
– – 0.2% 104
2025
Q3
$230K Buy
2,743
+1,678
+158% +$138K 0.16% 120
2025
Q2
$84.3K Buy
+1,065
New +$84.7K 0.07% 127
2024
Q4
$214K Buy
+2,151
New +$222K 0.17% 99

Other funds holding MRK

Chapman Financial Group's MRK Position: Q2 2026 in Review

Chapman Financial Group reduced its Merck (MRK) stake by 7.9% in Q2 2026, selling an estimated $23.4K and leaving 2,343 shares worth $301K. The position accounts for 0.2% of the portfolio, ranked #104.

Chapman Financial Group first reported a position in MRK in Q4 2024 and has held it in 6 quarters since. The position peaked at $306K in Q1 2026. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Chapman Financial Group held 2,343 shares of Merck worth $301K as of Q2 2026.
  • Chapman Financial Group sold 200 Merck shares in Q2 2026, an estimated $23.4K.
  • Merck made up 0.2% of Chapman Financial Group's portfolio in Q2 2026, its #104 holding.
  • Chapman Financial Group first reported a position in Merck in Q4 2024 and has held it in 6 quarters since.
  • Chapman Financial Group's Merck position peaked at $306K in Q1 2026.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Chapman Financial Group's 13F filing for Q2 2026, filed 5 Aug 2026.